Analytical Data
-
Gene name
FGF-15
- Application
-
Alternative Names
Short name:FGF-15
-
Species
Mouse
-
Source
E. coli
-
Tag
N- His-SUMO
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O35622
-
Expression Region
26-218aa
-
Protein Length
Partial
-
Molecular Weight
38.5 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FGF-15 (Fibroblast Growth Factor 15) is a member of the fibroblast growth factor family, primarily involved in regulating various biological processes, including cellular proliferation, differentiation, and metabolism. Recent research has spotlighted FGF-15 for its critical role in gut-brain communication, especially concerning bile acid metabolism and the regulation of energy homeostasis. Its expression is notably influenced by intestinal microbiota, linking it to gastrointestinal health and metabolic disorders. Scientists are particularly interested in FGF-15 due to its potential therapeutic applications in obesity, diabetes, and liver diseases, as it has been shown to improve insulin sensitivity and glucose tolerance in animal models. The recombinant production of FGF-15 has opened new avenues for studying its biological functions and interactions at the molecular level. Understanding the structure-function relationship of this growth factor can facilitate the development of novel treatments that target metabolic dysregulation. Additionally, FGF-15's involvement in signaling pathways presents opportunities for exploring its use as a biomarker for various diseases. Overall, the study of FGF-15 recombinant protein is a promising field that combines molecular biology, metabolic research, and therapeutic innovation, with the potential to significantly enhance our understanding of metabolic syndromes and develop effective interventions.
